SB1754 directs the Secretary of Defense to identify Chinese colleges, companies, and other entities tied to China’s military‑civil fusion effort and forbids federally funded U.S. research partners from engaging in scientific or technical exchanges with those entities when the work could have dual‑use military applications. The bill requires a publicly accessible, twice‑yearly updated website that lists prohibited research areas and, to the extent practicable, named Chinese entities of concern.
The bill matters because it shifts enforcement of research‑security controls into the Defense Department’s orbit, creates new administrative obligations for federal agencies, universities, and private companies that receive federal financial assistance, and makes loss of federal funds the central penalty for violations. Compliance will force institutions to screen collaborators, track past and contemplated relationships, and adapt grant and partnership policies to a Defense‑maintained public list of sensitive fields and entities.
At a Glance
What It Does
The bill prohibits 'covered entities'—federal research agencies, institutions of higher education and private research institutions receiving federal assistance, and U.S. companies with federal aid—from engaging in scientific research or technical exchanges with 'Chinese entities of concern' when the work bears on fields identified as supporting military‑civil fusion. It requires the Secretary of Defense to publish and update a website listing the covered research areas and, where practicable, relevant Chinese entities.
Who It Affects
Affected parties include federal research funders (like NSF and NIH), universities and private research institutions that accept any federal financial assistance, and U.S. companies that receive federal aid and pursue joint research or technical exchanges with Chinese partners. Defense and multiple cabinet agencies are tasked with maintaining the list and coordinating enforcement.
Why It Matters
SB1754 converts research‑security risk into a concrete funding veto: violation triggers preclusion from federal financial assistance. That raises compliance stakes for research administrators, contract officers, and corporate counsel, and could reshape university China‑policy controls and industry joint‑venture strategies.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
SB1754 builds a statutory firewall between U.S. federally supported research and Chinese institutions the Defense Department determines support the Chinese Communist Party’s military‑civil fusion strategy. The bill defines who counts as a 'Chinese entity of concern' (including specific categories of Chinese colleges and universities, state‑majority enterprises, privately held firms with military ties, and entities already identified on certain U.S. lists) and who counts as a 'covered entity' in the United States (federal research agencies, colleges and private research institutions receiving federal financial assistance, and U.S. companies that receive federal assistance).
Operationally, the Secretary of Defense must create and update a public website at least twice a year. That site will list the specific technical and scientific fields subject to the prohibition—initially calling out areas such as quantum computing, semiconductors, advanced materials, biotech, AI, photonics, robotics, 5G and future telecom generations, aerospace, and advanced nuclear technology—and, where practicable, identify named Chinese entities of concern.
The bill directs Defense to draw on Chinese government designations and to consult an interagency group when compiling and updating the list.Covered entities must report annually: within 180 days of enactment and each December 31 thereafter they must disclose current research relationships with listed Chinese entities, relationships they considered and declined, and relationships they terminated because of compliance concerns. The Secretary of Defense may contract independent auditors to verify those reports.
The bill also contains a carve‑out: Defense can issue regulations defining narrow exceptions for collaborations that demonstrably would not contribute substantially to military‑civil fusion goals.Enforcement is financially driven. If a non‑federal covered entity (a university, private research institute, or U.S. company receiving federal assistance) violates the prohibition or the reporting requirement, the bill bars that entity from receiving any federal financial assistance from the date of violation.
Defense must write implementing regulations in consultation with multiple agencies and coordinate enforcement across the federal government. The bill also prohibits U.S. private covered entities from forming partnerships or joint ventures with each other for the purpose of engaging in the proscribed research, closing a potential workaround through domestic collaboration.
The Five Things You Need to Know
The Secretary of Defense must publish and update a website at least twice per year listing prohibited research areas and, where practicable, named Chinese entities of concern.
Covered entities must file an initial disclosure within 180 days of enactment and an annual report every December 31 disclosing current, declined, and terminated research relationships with Chinese entities of concern.
The bill explicitly prevents U.S. private covered entities (companies that receive federal financial assistance) from forming partnerships or joint ventures with each other to conduct research that the statute bans.
Failure to comply with the prohibitions or reporting rules results in preclusion from receiving any federal financial assistance from the date of violation—a funding denial rather than criminal or civil fines.
The statute ties the scope of prohibited fields to Chinese government designations and directs Defense to consider over 280 disciplines identified by Chinese authorities as having national‑defense characteristics when defining the list.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Definitions: who is covered and who counts as a Chinese entity of concern
This subsection sets definitions that determine coverage and scope. 'Chinese entity of concern' is a broad, fact‑based category that includes Chinese universities tied to military programs (explicitly referencing the 'Seven Sons of National Defense'), state‑majority firms, private companies with PLA subcontracting or military production licenses, and entities on specified U.S. lists. 'Covered entity' reaches federal research agencies, any U.S. higher‑education or private research institution receiving federal financial assistance, and U.S. companies that receive federal financial assistance. These definitions are the gatekeepers for every other requirement and will drive how institutions screen partners and contracts.
Prohibition on research and technical exchanges with listed entities
This prohibition stops covered entities from engaging with Chinese entities of concern in scientific research or technical exchanges that have a direct bearing on or the potential for dual use in technologies deemed priority fields. The provision is not limited to funded collaborations; it applies to engagements and exchanges that could support technologies on the Defense‑maintained list. The subsection also adds a domestic prophylactic rule: U.S. private covered entities may not form joint ventures with each other for the purpose of conducting the proscribed research, preventing a transfer of know‑how through domestic intermediaries.
Defense‑maintained website listing prohibited fields and entities
Defense must produce a public, periodically updated website that names the specific scientific fields covered and, to the extent practicable, the Chinese entities of concern. The initial roster of fields includes areas commonly considered dual use—quantum, semiconductors, AI, biotech, photonics, robotics, aerospace, and advanced nuclear technologies. The statute requires Defense to consult multiple agencies and to consider Chinese government designations when compiling the list, effectively anchoring the U.S. scope to China’s own labeled defense‑relevant disciplines.
Regulatory exception for benign collaborations
The statute authorizes the Secretary of Defense to issue regulations carving out collaborative studies or projects that, by regulation, would not 'contribute substantially' to military‑civil fusion. That gives Defense discretion to preserve some benign, non‑sensitive academic collaborations, but only through a rulemaking process that will define the narrow standards for exception.
Annual disclosure and audit obligations for covered entities
Covered entities must submit detailed annual reports to Defense disclosing existing research relationships with Chinese entities of concern, declined proposals, and relationships terminated for violating the statute. Reports begin within 180 days of enactment and recur every December 31. Defense may contract independent auditors to verify reports, introducing an audit trail and potential spot checks that institutions must prepare to withstand.
Enforcement: funding preclusion and delegated rulemaking
Enforcement is civil and administrative: covered non‑federal entities that violate the prohibitions or reporting requirements are precluded from receiving federal financial assistance starting on the date of violation. The Secretary of Defense must promulgate regulations, in consultation with an interagency group, to enforce the statute and coordinate cross‑agency implementation. The provision uses funding denial rather than criminal penalties, but the practical effect can be existential for institutions dependent on federal grants.
This bill is one of many.
Codify tracks hundreds of bills on Defense across all five countries.
Explore Defense in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Department of Defense and national security policymakers — the bill centralizes control over a public list and enforcement tools that directly reduce avenues for China to access dual‑use U.S. research.
- U.S. defense contractors and firms not engaged with China — they gain a clearer barrier against inadvertent technology transfer and potentially reduced competition from firms that previously leveraged university ties to access U.S. research.
- Compliance vendors and legal advisors — universities and companies will need third‑party support to screen partners, track collaborations, and prepare the required disclosures and audit responses.
Who Bears the Cost
- Research universities and academic labs that collaborate with Chinese peers — they must build new screening processes, alter collaboration policies, and may lose access to talent and datasets, with direct operational and reputational costs.
- U.S. companies with cross‑border R&D — firms that rely on Chinese partnerships or supply chains will face restrictions on joint projects and must restructure or forgo collaborations in specified fields, potentially slowing innovation cycles.
- Federal agencies and the Department of Defense — assigned to maintain the list, coordinate interagency input, and run audits, agencies will need staff and funding to manage updates, adjudicate exceptions, and enforce preclusion decisions.
Key Issues
The Core Tension
The bill confronts a classic policy trade‑off: protect sensitive U.S. capabilities by severing research pathways to Chinese military‑linked entities, or preserve the openness of scientific collaboration that underpins innovation and U.S. competitiveness; the statute reduces one risk by increasing another—administrative burden and potential curtailment of benign research—without offering a clear, durable mechanism to distinguish harmful from harmless collaboration in fast‑moving fields.
The bill leans on two judgment calls that will drive real implementation headaches. First, the 'Chinese entity of concern' definition combines objective indicators (state ownership, PLA funding, listed status) with discretionary ones (institutions 'involved in' military‑civil fusion or that 'create platforms' for it).
That mixes bright‑line and fuzzy criteria, creating predictable disputes over designation error rates, appeals, and how long institutions remain listed. Second, tying prohibited research fields to Chinese government designations and a Defense‑maintained list means the statute’s substantive scope can be expansive and will evolve with Chinese policy choices.
Institutions will need dynamic compliance processes rather than one‑time reviews.
Practical enforcement raises additional tradeoffs. Using funding denial as the primary penalty avoids criminalizing collaborations but imposes a blunt instrument that can disrupt research ecosystems and unintentionally penalize collaborations that are low‑risk or already terminated.
The audit authority helps verification, but audits require funding, procedural safeguards, and a process for institutions to contest findings. Finally, the authorized exception for 'non‑substantial' collaborations depends entirely on forthcoming Defense regulations; until those rules appear, universities and firms face legal uncertainty that will chill borderline collaborations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.